Projects Under Development

Postsurgical therapeutics has developed proprietary PLGA based drug delivery systems with high efficiency and tuneable release characteristics. Postsurgical's PLGA MS or ISG formulation technology is applied to two current programs with four projects under development including pain therapeutics program in partnership with UPEX-MED. The program consists of two projects. The first project is for the treatment of pain associated with hemophilic arthropathy (PTI-101) and the second project is for the treatment of pain associated with diabetic neuropathy (PTI-102). Postsurgical also has an oncology program with two projects. The first Oncology project is for local postsurgical targeted therapy (PTI-103) treatment and the second is for combinatorial local and oral targeted therapy (PTI-104).